Recent scientific advancements have unveiled the potential of cannabidiol (CBD), a primary compound found in Cannabis, in combatting oral cancer. A novel study emphasizes CBD’s effectiveness in reducing the viability of oral squamous cell carcinoma cells, suggesting its use as an innovative adjuvant therapy in cancer treatment.
Cytotoxic effects were observed, with 64%, 96%, and 99% reductions in cell viability using 25 µM, 50 µM, and 100 µM concentrations, respectively, over 72 hours. The effects were both dose- and time-dependent.
CBD induced significant morphological alterations and heightened DNA damage. At 25 µM concentration, marked morphological changes persisted, and DNA damage increased significantly in certain cells.
**CBD shows promise as a therapeutic agent** for its cytotoxic effects against oral squamous cell carcinoma cells. However, to harness its full potential as a cancer treatment, further investigation into the underlying mechanisms is required.
This groundbreaking study highlights CBD’s potential in oncology, offering hope for new therapeutic approaches to oral cancer treatment. With rigorous further research and exploration, CBD could be pivotal in cancer therapy.
For more information, visit the study at PubMed.
CATEGORY: Cancer
Unlocking the Power of CBD: New Breakthroughs for Epilepsy & Mental Health Cannabidiol oil (CBD)…
Breakthrough: THC May Help Heal PTSD Trauma Recent scientific research has unveiled that delta-9-tetrahydrocannabinol (THC),…
Unlocking Cannabis' Brain Power: A New Frontier in Neuroprotection For thousands of years, Cannabis sativa…
Flavors with a Twist: Cannabinoids Revealed as Taste Toppers The discovery of cannabinoids as influential…
Unlocking New Hope: Cannabinoids Take Center Stage in Migraine Treatment Migraine is a common and…
Breakthrough Discovery: Cannabis Compound Shows Promise in Reducing Brain Injury Damage In a groundbreaking study,…